A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors
一项针对儿童的 1 期、首次、多中心研究,旨在评估溶瘤疱疹病毒 talimogene laherparepvec 在患有晚期实体瘤的儿科患者中的安全性和有效性。
期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2023.1183295
Moreno, Lucas; Teira, Pierre; Croop, James M; Gerber, Nicolas U; André, Nicolas; Aerts, Isabelle; Gros Subias, Luis; De Wilde, Bram; Bautista, Francisco; Turpin, Brian; Kunduri, Srinivasa; Hamidi, Ali; Lawrence, Tatiana; Streby, Keri A